TYRA— Tyra Biosciences, Inc.

$33.17-1.25%

NasdaqMaterialsPharmaceutical Preparations

2 insiders sold $791K in the last 30 days — 11.0x above baseline

Sell Velocity Score

10.99x

Sell Rate (90d)

247.72 sh/day

Sell Baseline Rate

—

Unique Sellers (90d)

Price Chart

Loading…

Insider Transactions

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-03-25	2026-03-27	KAPLAN GILLA	Director	Sale	14.3K	$36.97	$529K	28.2K	View ↗
2026-02-12	2026-02-13	Bensen Daniel	Chief Discovery Officer	Sale	8,000	$32.87	$263K	147.0K	View ↗

No recent congressional transactions.

Revenue

No data

Operating Income

No data

Net Income

No data

Free Cash Flow

-$95.3M

-35.3% YoY

No annual data found.

TYRA BIOSCIENCES AND BCAN ESTABLISH MAY 21 AS UPPER TRACT UROTHELIAL CANCER (UTUC) AWARENESS DAY

Tyra Biosciences Stock Has Soared 280% in a Year. One Fund Just Disclosed Buying More Shares

Assessing Tyra Biosciences (TYRA) Valuation After Strong One Year Share Price Momentum

Tyra Biosciences, Inc. (TYRA) Presents at Bank of America Global Healthcare Conference 2026 Transcript